Lumos Diagnostics Holdings Limited (ASX:LDX)

ASX:LDX Income Statement

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Revenue	12.4	11.13	10.54	11.63	18.85
Revenue Growth (YoY)	11.40%	5.66%	-9.41%	-38.31%	225.25%
Cost of Revenue	4.72	4.57	5.21	9.76	10.25
Gross Profit	7.68	6.56	5.32	1.88	8.6
Selling, General & Admin	13.11	11.5	11.64	21.89	18.36
Research & Development	0.11	0.07	0.25	1.33	1.24
Operating Expenses	15.75	14.22	15.56	28.78	19.6
Operating Income	-8.07	-7.66	-10.23	-26.9	-11
Interest Expense	-0.56	-1.02	-2.39	-0.57	-4.22
Interest & Investment Income	0.06	0.05	0.02	0	-
Other Non Operating Income (Expenses)	1.44	-0	2.04	-0.02	0.19
EBT Excluding Unusual Items	-7.13	-8.64	-10.56	-27.5	-15.03
Merger & Restructuring Charges	-	-	-	-1.68	-
Impairment of Goodwill	-	-	-	-1.02	-
Gain (Loss) on Sale of Investments	-	-	-	-0.2	-
Gain (Loss) on Sale of Assets	-0.05	0.04	1.59	0.02	-
Asset Writedown	-	-	-	-15.35	-
Pretax Income	-7.18	-8.59	-8.97	-45.72	-15.03
Net Income	-7.18	-8.59	-8.97	-45.72	-15.03
Net Income to Common	-7.18	-8.59	-8.97	-45.72	-15.03
Shares Outstanding (Basic)	680	463	235	152	-
Shares Outstanding (Diluted)	680	463	235	152	-
Shares Change (YoY)	46.85%	97.23%	54.17%	-	-
EPS (Basic)	-0.01	-0.02	-0.04	-0.30	-
EPS (Diluted)	-0.01	-0.02	-0.04	-0.30	-
Free Cash Flow	-9.39	0.89	-9.76	-20.56	-16.77
Free Cash Flow Per Share	-0.01	0.00	-0.04	-0.14	-
Gross Margin	61.93%	58.96%	50.54%	16.12%	45.62%
Operating Margin	-65.07%	-68.79%	-97.13%	-231.32%	-58.35%
Profit Margin	-57.93%	-77.19%	-85.15%	-393.16%	-79.72%
Free Cash Flow Margin	-75.70%	8.03%	-92.67%	-176.78%	-88.96%
EBITDA	-7.46	-6.97	-9.07	-25.67	-10.69
EBITDA Margin	-60.19%	-62.64%	-86.10%	-220.70%	-56.70%
D&A For EBITDA	0.61	0.69	1.16	1.24	0.31
EBIT	-8.07	-7.66	-10.23	-26.9	-11
EBIT Margin	-65.07%	-68.79%	-97.13%	-231.32%	-58.35%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.